DEPOMED (DEPO) Covered Calls

DEPOMED covered calls DepoMed, Inc company, is focused on the development and commercialization of differentiated products that address large and growing markets and are based on proprietary oral drug delivery technologies.

You can sell covered calls on DEPOMED to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for DEPO (prices last updated Wed 4:16 PM ET):

DEPOMED (DEPO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
8.21 -0.05 8.21 8.29 1.1M - 0.5B
Covered Calls For DEPOMED (DEPO)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jul 20 8 0.20 8.09 -1.1% -133.8%
Aug 17 8 0.70 7.59 5.4% 63.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Depomed, Inc. manufactures and distributes pharmaceutical products. It is a specialty pharmaceutical company focused on the development and commercialization of products to treat pain and other central nervous system conditions. Its core products include Gralise (gabapentin), a once-daily product for the management of postherpetic neuralgia; Zipsor (diclofenac potassium) liquid filled capsules, a product for the treatment of mild to moderate acute pain; and Lazanda (fentanyl) nasal spray, a product for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. The company has developed and licensed a drug-delivery technology, Acuform. Depomed was founded by John W. Shell on August 7, 1995 and is headquartered in Newark, CA.